MedPath

Cymbalta

These highlights do not include all the information needed to use Cymbalta safely and effectively. See full prescribing information for Cymbalta.Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules for Oral Use.Initial U.S. Approval: 2004

Approved
Approval ID

7db112de-473a-4407-bc1c-35d0ab748700

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 22, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Duloxetine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-657
Application NumberNDA021427
Product Classification
M
Marketing Category
C73594
G
Generic Name
Duloxetine hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 4, 2010
FDA Product Classification

INGREDIENTS (11)

Duloxetine hydrochlorideActive
Quantity: 20 mg in 1 1
Code: 9044SC542W
Classification: ACTIM
GelatinInactive
Code: 2G86QN327L
Classification: IACT
HypromellosesInactive
Code: 3NXW29V3WO
Classification: IACT
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MM2/S)Inactive
Code: 24P2YXD2PW
Classification: IACT
Sodium lauryl sulfateInactive
Code: 368GB5141J
Classification: IACT
TalcInactive
Code: 7SEV7J4R1U
Classification: IACT
Titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
SucroseInactive
Code: C151H8M554
Classification: IACT
Triethyl citrateInactive
Code: 8Z96QXD6UM
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cymbalta - FDA Drug Approval Details